Latest Ischaemic heart disease Stories
Cardium Therapeutics (NYSE Amex: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA.
In addition to the many risk factors associated with poor health, reducing body mass index (BMI) will have a considerable and independent impact if you want to reduce the risk of developing ischemic heart disease (IHD).
A Mendelian randomization analysis conducted by Børge Nordestgaard of Copenhagen University Hospital, Denmark and colleagues, using data from observational studies, supports a causal relationship between body mass index (BMI) and risk for ischemic heart disease (IHD).
Delivering a full-term baby of small birth weight has been shown to be an independent indicator of later heart disease for the mother, and as equivalent in risk as high blood pressure and diabetes.
Small for their gestational age, infants account for approximately 10 percent of births, and increased maternal risk for ischemic heart disease in women.
Patients who had leaky mitral heart valves repaired along with bypass surgery had with healthier hearts than those who had bypass only.
A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina.
Australian researchers have found evidence that heart failure is associated with a decline in people's mental processes and a loss of grey matter in the brain.